{"id":"tp-42441","type":"article-newspaper","title":"GSK Q3 Sales Rise 4% as Core EPS Beats Consensus by 4.2 Pence","author":"John Kim","publisher":"TOKENPOST Inc.","url":"https://www.tokenpost.com/news/business/42441","datePublished":"2026-10-28T07:52:55.000Z","dateModified":"2026-10-28T07:52:55.000Z","language":"en","abstract":"Specialty Medicines sales grew 15% at constant exchange rates, and GSK reaffirmed its 2026 outlook.","section":"Business","references":[{"title":"its earlier 2026 guidance","url":"https://www.tokenpost.com/news/business/42375"}]}